|
Myasthenia Gravis, Autoimmune, Experimental
|
C10.668.758.725.300 |
|
|
Patient Identification Systems
|
D010355 |
[Procedures and use of devices to maintain knowledge of PATIENTS locations inside and outside the healthcare facility.
, Organized procedures for establishing patient identity, including use of bracelets, etc.
] |
|
Multiple Endocrine Neoplasia
|
D009377 |
[A group of autosomal dominant diseases characterized by the combined occurrence of tumors involving two or more ENDOCRINE GLANDS that secrete PEPTIDE HORMONES or AMINES. These neoplasias are often benign but can be malignant. They are classified by the endocrine glands involved and the degree of aggressiveness. The two major forms are MEN1 and MEN2 with gene mutations on CHROMOSOME 11 and CHROMOSOME 10, respectively.
] |
|
Schistosomiasis
|
C01.610.335.865.859 |
|
|
Patient Isolation
|
D010356 |
[The segregation of patients with communicable or other diseases for a specified time. Isolation may be strict, in which movement and social contacts are limited; modified, where an effort to control specified aspects of care is made in order to prevent cross infection; or reverse, where the patient is secluded in a controlled or germ-free environment in order to protect him or her from cross infection.
] |
|
Neoplasms, Multiple Primary
|
D009378 |
[Two or more abnormal growths of tissue occurring simultaneously and presumed to be of separate origin. The neoplasms may be histologically the same or different, and may be found in the same or different sites.
] |
|
Deinococcus
|
D034301 |
[A genus of gram-positive aerobic cocci found in the soil, that is highly resistant to radiation, especially ionizing radiation (RADIATION, IONIZING). Deinococcus radiodurans is the type species.
] |
|
Patient Isolators
|
D010357 |
[Equipment used to prevent contamination of and by patients, especially those with infections. This includes plastic surgical isolators and specially designed spaces used to protect patients.
] |
|
Neoplasms, Glandular and Epithelial
|
D009375 |
[Neoplasms composed of glandular tissue, an aggregation of epithelial cells that elaborate secretions, and of any type of epithelium itself. The concept does not refer to neoplasms located in the various glands or in epithelial tissue.
] |
|
Patient Participation
|
D010358 |
[Patient involvement in the decision-making process in matters pertaining to health.
] |
|
Neoplasms, Hormone-Dependent
|
D009376 |
[Certain tumors that 1, arise in organs that are normally dependent on specific hormones and 2, are stimulated or caused to regress by manipulation of the endocrine environment.
] |
|
Patient Readmission
|
D010359 |
[Subsequent admissions of a patient to a hospital or other health care institution for treatment.
] |
|
Neoplasms, Germ Cell and Embryonal
|
D009373 |
[Neoplasms composed of primordial GERM CELLS of embryonic GONADS or of elements of the germ layers of the EMBRYO, MAMMALIAN. The concept does not refer to neoplasms located in the gonads or present in an embryo or FETUS.
] |
|
Optic Atrophy, Hereditary, Leber
|
C16.320.290.564.400 |
|
|
Neoplasms, Experimental
|
D009374 |
[Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms.
] |
|
Acids, Aldehydic
|
D02.241.152 |
|
|
Health Services Misuse
|
N02.421.380 |
|
|
Neoplasms by Site
|
D009371 |
[A collective term for precoordinated organ/neoplasm headings locating neoplasms by organ, as BRAIN NEOPLASMS; DUODENAL NEOPLASMS; LIVER NEOPLASMS; etc.
] |
|
Neoplasms, Connective Tissue
|
D009372 |
[Neoplasms composed of connective tissue, including elastic, mucous, reticular, osseous, and cartilaginous tissue. The concept does not refer to neoplasms located in connective tissue.
] |
|
Leukemia Inhibitory Factor
|
D23.529.374.470 |
|
